CHICAGO, Sept. 22 /PRNewswire-FirstCall/ — Allscripts Healthcare
Solutions, Inc. (“Allscripts”) (Nasdaq: MDRX), the leading provider of
clinical software, connectivity and information solutions that physicians use
to improve healthcare, announced today that it convened its 2008 annual
meeting of stockholders on September 22, 2008. As previously announced, the
meeting was immediately adjourned until 10:00 a.m. (CDT) on October 6, 2008 at
the offices of Sidley Austin LLP, One South Dearborn Street, Chicago, IL
60603. At the annual meeting, Allscripts stockholders will be asked to
approve certain actions required to be taken by Allscripts in connection with
the proposed transactions with Misys plc, among other matters.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b)
Completion of the transactions is subject to certain conditions, including
approvals by the stockholders of Allscripts and the shareholders of Misys plc
and other customary closing conditions. Subject to the satisfaction of these
closing conditions, the transactions are expected to be completed on or about
October 10, 2008.
About Allscripts
Allscripts is the leading provider of clinical software, connectivity and
information solutions that physicians use to improve healthcare. The
company’s unique solutions inform, connect and transform healthcare,
delivering improved care at lower cost. More than 40,000 physicians and
thousands of other healthcare professionals in clinics, hospitals and extended
care facilities nationwide utilize Allscripts to automate everyday tasks such
as writing prescriptions, documenting patient care, managing billing and
scheduling, and safely discharging patients, as well as to connect with key
information and stakeholders in the healthcare system. To learn more, visit
Allscripts at https://www.allscripts.com.
Forward-Looking Statements
This communication contains forward-looking statements. Those
forward-looking statements include all statements other than those made solely
with respect to historical fact. Forward-looking statements may be identified
by words such as “believes,” “expects,” “anticipates,” “estimates,”
“projects,” “intends,” “should,” “seeks,” “future,” “continue,” or the
negative of such terms, or other comparable terminology. Such statements
include, but are not limited to, statements about the expected benefits of the
transaction involving Allscripts, Misys Healthcare Systems, LLC (“MHS”) and
Misys plc (“Misys”), including potential synergies and cost savings, future
financial and operating results, and the combined company’s plans and
objectives. In addition, statements made in this communication about
anticipated financial results, future operational improvements and results or
conditions and approvals are also forward-looking statements. Such forward-
looking statements are subject to numerous risks, uncertainties, assumptions
and other factors that are difficult to predict and that could cause actual
results to vary materially from those expressed in or indicated by them. Such
factors may include, but are not limited to: (1) the occurrence of any event,
development, change or other circumstances that could give rise to the
termination of the merger agreement; (2) the outcome of any legal proceedings
that have been or may be instituted against Allscripts, Misys or MHS and
others following announcement of entering into the merger agreement; (3) the
inability to complete the proposed transaction due to the failure to obtain
stockholder or shareholder approval or the failure of any party to satisfy
other conditions to completion of the proposed transaction; (4) risks that the
proposed transaction disrupts current plans and operations and potential
difficulties in employee retention as a result of the merger; (5) the ability
to recognize the benefits of the merger; (6) legislative, regulatory and
economic developments; and (7) other factors described in filings with the
Securities and Exchange Commission. Many of the factors that will determine
the outcome of the subject matter of this communication are beyond
Allscripts’, Misys’ and MHS’ ability to control or predict. Allscripts can
give no assurance that any of the transactions related to the merger will be
completed or that the conditions to the transactions will be satisfied.
Allscripts undertakes no obligation to revise or update any forward-looking
statement, or to make any other forward-looking statements, whether as a
result of new information, future events or otherwise. Allscripts is not
responsible for updating the information contained in this communication
beyond the published date, or for changes made to this communication by wire
services or Internet service providers.
Important Additional Information and Where to Find It
A portion of this communication is being made in respect of the proposed
business combination involving a subsidiary of Allscripts and MHS, a wholly
owned subsidiary of Misys. In connection with this proposed transaction,
Allscripts has filed with the Securities and Exchange Commission (the “SEC”) a
definitive proxy statement. BEFORE MAKING ANY DECISION WITH RESPECT TO THE
PROPOSED TRANSACTION, INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE
PROXY STATEMENT AND OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE,
BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT ALLSCRIPTS AND THE PROPOSED
TRANSACTION. Investors and security holders can obtain copies of Allscripts’
materials (and all other offer documents filed with the SEC) when available,
at no charge on the SEC’s website: http://www.sec.gov. Copies can also be
obtained at no charge by directing a request for such materials to Allscripts
at 222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654, Attention:
Lee Shapiro, Secretary. Investors and security holders may also read and copy
any reports, statements and other information filed by Allscripts with the
SEC, at the SEC public reference room at 100 F Street, N.E., Washington, D.C.
20549. Please call the SEC at 1-800-SEC-0330 or visit the SEC’s website for
further information on its public reference room. Allscripts’ directors,
executive officers and other members of management and employees may, under
the rules of the SEC, be deemed to be participants in the solicitation of
proxies from the stockholders of Allscripts in favor of the proposed
transaction. Information about Allscripts, its directors and its executive
officers, and their ownership of Allscripts’ securities, is set forth in its
definitive proxy statement for the 2008 Annual Meeting of Stockholders, which
was filed with the SEC on August 21, 2008.
SOURCE Allscripts Healthcare Solutions, Inc.
CONTACT: Dan Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com, or Todd Stein, Senior Manager|Public Relations,
+1-312-506-1216, todd.stein@allscripts.com, both of Allscripts Healthcarev
Solutions, Inc.
Photo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
Web site: https://www.allscripts.com
(MDRX)